Selected research
Market Structure
Global Surface Protein gp120 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Surface Protein gp120 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Surface Protein gp120 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Surface Protein gp120 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Surface Protein gp120 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Surface Protein gp120 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Surface Protein gp120 include Sanofi Pasteur SA, GlaxoSmithKline Plc, ViiV Healthcare Limited, United Biomedical, Inc., TeneoBio Inc and Osel, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Surface Protein gp120 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Surface Protein gp120 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Surface Protein gp120 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Surface Protein gp120 market size, projected growth trends, production technologies, key applications, and end-use industries.
Surface Protein gp120 Segment by Company
Sanofi Pasteur SA
GlaxoSmithKline Plc
ViiV Healthcare Limited
United Biomedical, Inc.
TeneoBio Inc
Osel, Inc.
Surface Protein gp120 Segment by Type
BMD-104
DS-003
HNG-156
M-48U1
Others
Surface Protein gp120 Segment by Application
Hospital
Clinic
Others
Surface Protein gp120 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Surface Protein gp120 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Surface Protein gp120 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Surface Protein gp120.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Surface Protein gp120 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Surface Protein gp120 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Surface Protein gp120 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Surface Protein gp120 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- BMD-104
- DS-003
- HNG-156
- M-48U1
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Sanofi Pasteur SA
- GlaxoSmithKline Plc
- ViiV Healthcare Limited
- United Biomedical, Inc.
- TeneoBio Inc
- Osel, Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Surface Protein gp120 Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Surface Protein gp120 Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Surface Protein gp120 Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Surface Protein gp120 Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Surface Protein gp120 Market Dynamics
- 2.1 Surface Protein gp120 Industry Trends
- 2.2 Surface Protein gp120 Industry Drivers
- 2.3 Surface Protein gp120 Industry Opportunities and Challenges
- 2.4 Surface Protein gp120 Industry Restraints
3 Surface Protein gp120 Market by Manufacturers
- 3.1 Global Surface Protein gp120 Revenue by Manufacturers (2021-2026)
- 3.2 Global Surface Protein gp120 Sales by Manufacturers (2021-2026)
- 3.3 Global Surface Protein gp120 Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Surface Protein gp120 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Surface Protein gp120 Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Surface Protein gp120 Manufacturers, Product Type & Application
- 3.7 Global Surface Protein gp120 Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Surface Protein gp120 Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Surface Protein gp120 Players Market Share by Revenue in 2025
- 3.8.3 2025 Surface Protein gp120 Tier 1, Tier 2, and Tier 3
4 Surface Protein gp120 Market by Type
- 4.1 Surface Protein gp120 Type Introduction
- 4.1.1 BMD-104
- 4.1.2 DS-003
- 4.1.3 HNG-156
- 4.1.4 M-48U1
- 4.1.5 Others
- 4.2 Global Surface Protein gp120 Sales by Type
- 4.2.1 Global Surface Protein gp120 Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Surface Protein gp120 Sales by Type (2021-2032)
- 4.2.3 Global Surface Protein gp120 Sales Market Share by Type (2021-2032)
- 4.3 Global Surface Protein gp120 Revenue by Type
- 4.3.1 Global Surface Protein gp120 Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Surface Protein gp120 Revenue by Type (2021-2032)
- 4.3.3 Global Surface Protein gp120 Revenue Market Share by Type (2021-2032)
5 Surface Protein gp120 Market by Application
- 5.1 Surface Protein gp120 Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Surface Protein gp120 Sales by Application
- 5.2.1 Global Surface Protein gp120 Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Surface Protein gp120 Sales by Application (2021-2032)
- 5.2.3 Global Surface Protein gp120 Sales Market Share by Application (2021-2032)
- 5.3 Global Surface Protein gp120 Revenue by Application
- 5.3.1 Global Surface Protein gp120 Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Surface Protein gp120 Revenue by Application (2021-2032)
- 5.3.3 Global Surface Protein gp120 Revenue Market Share by Application (2021-2032)
6 Global Surface Protein gp120 Sales by Region
- 6.1 Global Surface Protein gp120 Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Surface Protein gp120 Sales by Region (2021-2032)
- 6.2.1 Global Surface Protein gp120 Sales by Region (2021-2026)
- 6.2.2 Global Surface Protein gp120 Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Surface Protein gp120 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Surface Protein gp120 Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Surface Protein gp120 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Surface Protein gp120 Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Surface Protein gp120 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Surface Protein gp120 Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Surface Protein gp120 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Surface Protein gp120 Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Surface Protein gp120 Revenue by Region
- 7.1 Global Surface Protein gp120 Revenue by Region
- 7.1.1 Global Surface Protein gp120 Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Surface Protein gp120 Revenue by Region (2021-2026)
- 7.1.3 Global Surface Protein gp120 Revenue by Region (2027-2032)
- 7.1.4 Global Surface Protein gp120 Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Surface Protein gp120 Revenue (2021-2032)
- 7.2.2 North America Surface Protein gp120 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Surface Protein gp120 Revenue (2021-2032)
- 7.3.2 Europe Surface Protein gp120 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Surface Protein gp120 Revenue (2021-2032)
- 7.4.2 Asia-Pacific Surface Protein gp120 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Surface Protein gp120 Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Surface Protein gp120 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi Pasteur SA
- 8.1.1 Sanofi Pasteur SA Company Information
- 8.1.2 Sanofi Pasteur SA Business Overview
- 8.1.3 Sanofi Pasteur SA Surface Protein gp120 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi Pasteur SA Surface Protein gp120 Product Portfolio
- 8.1.5 Sanofi Pasteur SA Recent Developments
- 8.2 GlaxoSmithKline Plc
- 8.2.1 GlaxoSmithKline Plc Company Information
- 8.2.2 GlaxoSmithKline Plc Business Overview
- 8.2.3 GlaxoSmithKline Plc Surface Protein gp120 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 GlaxoSmithKline Plc Surface Protein gp120 Product Portfolio
- 8.2.5 GlaxoSmithKline Plc Recent Developments
- 8.3 ViiV Healthcare Limited
- 8.3.1 ViiV Healthcare Limited Company Information
- 8.3.2 ViiV Healthcare Limited Business Overview
- 8.3.3 ViiV Healthcare Limited Surface Protein gp120 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 ViiV Healthcare Limited Surface Protein gp120 Product Portfolio
- 8.3.5 ViiV Healthcare Limited Recent Developments
- 8.4 United Biomedical, Inc.
- 8.4.1 United Biomedical, Inc. Company Information
- 8.4.2 United Biomedical, Inc. Business Overview
- 8.4.3 United Biomedical, Inc. Surface Protein gp120 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 United Biomedical, Inc. Surface Protein gp120 Product Portfolio
- 8.4.5 United Biomedical, Inc. Recent Developments
- 8.5 TeneoBio Inc
- 8.5.1 TeneoBio Inc Company Information
- 8.5.2 TeneoBio Inc Business Overview
- 8.5.3 TeneoBio Inc Surface Protein gp120 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 TeneoBio Inc Surface Protein gp120 Product Portfolio
- 8.5.5 TeneoBio Inc Recent Developments
- 8.6 Osel, Inc.
- 8.6.1 Osel, Inc. Company Information
- 8.6.2 Osel, Inc. Business Overview
- 8.6.3 Osel, Inc. Surface Protein gp120 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Osel, Inc. Surface Protein gp120 Product Portfolio
- 8.6.5 Osel, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Surface Protein gp120 Value Chain Analysis
- 9.1.1 Surface Protein gp120 Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Surface Protein gp120 Production Mode & Process
- 9.2 Surface Protein gp120 Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Surface Protein gp120 Distributors
- 9.2.3 Surface Protein gp120 Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst